The FTC Strikes Out: Drug Manufacturers Refuse To Play Ball And Delist Orange Book Patents In Response To FTC Warning Letters
Published:
Jul 01, 2024
What You Need to Know Key takeaway #1 Over the past eight months, the FTC sent two rounds of warning letters to manufacturers stating the agency's position that certain patents listed in the Orange Book may violate antitrust laws. Key takeaway #2 In response to the first round of letters,...
Read More
Read More